Craif

Craif's Urine Test Kit Enhances Early Cancer Detection PossibilitiesThe urine test kit developed by Craif can improve the possibility of early cancer detection. Leveraging its expertise in nanoscale processing technology in the field of bioscience, Craif has developed and markets test kits that allow for easy and highly sensitive detection of the risk of seven types of cancers, including pancreatic and lung cancer, as early as the first stage. These kits efficiently capture and measure tiny ribonucleic acid molecules known as miRNA2 in urine, which are otherwise difficult to detect. Combined with AI-based analytical methods, these tests achieve higher accuracy.